Sprint Bioscience AB
SPRINT SE0006343745
ICB 2010 : Health Care / Health CareAnnual Performance 1
| 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| -52% | -86% | 57% | -11% | 4% |
Annual Insiders Turnover, USD 2
1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);
Insider Activity
| Person | Price | Shares | Total | Published | Completed |
|---|---|---|---|---|---|
| Johan Emilsson CEO |
1.30 SEK |
20,000 Bought |
25,900 SEK |
22/12/2023 | 22/12/2023 |
| Fredrik Lehmann DIR |
2.10 SEK |
20,000 Bought |
42,000 SEK |
21/11/2023 | 21/11/2023 |
| Fredrik Lehmann DIR |
2.10 SEK |
20,000 Bought |
42,000 SEK |
24/11/2023 | 21/11/2023 |
| Mathias Skalmstad CEO |
0.98 SEK |
2,000 Bought |
1,960 SEK |
25/08/2023 | 25/08/2023 |
| Mathias Skalmstad CEO |
1.02 SEK |
32,000 Bought |
32,640 SEK |
25/08/2023 | 25/08/2023 |
| Jan-erik Nyström DIR |
4.66 SEK |
3,726 Bought |
17,363 SEK |
20/09/2021 | 20/09/2021 |
| Rune Nordlander DIR |
4.82 SEK |
4,486 Bought |
21,623 SEK |
15/09/2021 | 13/09/2021 |
| Rune Nordlander DIR |
4.93 SEK |
33,831 Bought |
166,787 SEK |
14/09/2021 | 10/09/2021 |
| Rune Nordlander DIR |
4.96 SEK |
34,040 Bought |
168,975 SEK |
14/09/2021 | 09/09/2021 |
| Rune Nordlander CB |
5.10 SEK |
392,156 Bought |
1,999,996 SEK |
09/04/2021 | 08/04/2021 |